Evaluating the Occurrence of Adverse Events Among Pediatric Patients Exposed to IV Lacosamide Using RWD
Epilepsy affects the pediatric population with an estimated prevalence of 6.8 per 1,000 insured children. Newly introduced antiepileptic drugs (AEDs) may be used off-label in children with epilepsy before completion of pediatric regulatory studies, creating an opportunity to evaluate the real-world use and safety of these drugs in children to support the pediatric clinical trial […]